BIO-ONE

Item 7 details the initial investment at $115,895-$188,595, with a $60,000 franchise fee that's on the higher side for home services (category norm ~$40K). Ongoing fees include 7.5% royalty (greater of minimum or gross sales percentage), 2% brand fund (minimum $200/month), and a $650 monthly technology fee—elevated versus peers' 6% royalties and 1% ads. Item 19 reveals average gross revenue of $372,962, but a stark 0% EBITDA margin signals thin profitability after expenses; estimated profits swing wildly from -$621,951 to +$201,288, highlighting high variability likely from job scale and local demand. With 144 franchise locations and just 3 corporate, the system leans heavily on owners, but 17 terminations (roughly 12% of units) and 2 transfers suggest churn—above average for services categories.

SBA stats flag 77 loans averaging $157,548 with a 6.5% default rate, better than many startups (industry ~15%) but warranting scrutiny amid litigation over contract breaches and supply mandates. No massive growth projections noted, yet bio-medical waste demand grows with aging populations. For risk-tolerant investors eyeing $300K+ top-line potential in underserved markets, Bio-One fits if you stomach the fee load and profit volatility—but low margins demand ironclad cost control to avoid the red side of that range.